Idiopathic pulmonary fibrosis (IPF) is a fibrotic lung disease, with unknown etiopathogenesis and suboptimal therapeutic options. Due to the lack of clinical efficacy of standard immuno-suppressants in IPF, the role of the immune response in this disease remains elusive. Nevertheless, previous reports have shown that increased T cell numbers and phenotype is predictive of prognosis in IPF, suggesting that these cells 
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Introduction:
Despite the advent of approved pharmacological interventions, IPF remains one the most challenging interstitial lung diseases to manage clinically 1 . This lung-localized disease is characterized histologically by the presence of usual interstitial pneumonia, and specifically by the presence of fibroblastic foci, which are believed to be the site of active tissue remodeling. The fibrotic triggers in IPF are unknown but it is speculated that persistent lung injury leads to alveolar epithelial cell injury and death, and subsequent aberrant repair mechanism(s) ablates the alveolus 2 . The nature of the factors dictating these aberrant repair mechanisms in IPF are unknown.
Experimental evidence and histological analysis indicate that there are increased numbers of innate and adaptive immune cells (particularly lymphocytes [3] [4] [5] [6] [7] , which might disrupt normal lung repair in IPF. Peripheral blood IPF T cells exhibit transcript and/or a surface protein expression signature characterized by a loss of one or more costimulatory molecules, including CD28 and ICOS receptors 4, 8 . Indeed, the surface expression of the co-stimulatory molecules CD28 and ICOS are lower in IPF relative to normal peripheral blood CD8 + cytotoxic but not CD4 + helper T cells 9 . Likewise, the accumulation of CD3 + T cells and CD20 + B cells in lymphocyte aggregates is well documented in the IPF lungs 7 .
Further, there is impairment of Semaphorin 7a-expressing regulatory T cells in bronchoalveolar lavage (BAL) and lung explants from IPF patients 5, 6 . Finally, there is a high prevalence of monoclonality and oligoclonality of T cells in IPF, suggesting that these cells might be active in the lungs of these patients [10] [11] [12] [13] .
In this report, a detailed characterization of the phenotype and function of IPF anti-CTLA4 mAb, but not anti-PD1 mAb, treatment of humanized NSG mice exacerbated pulmonary fibrosis, which correlated with an expansion of IPF T cells in these mice.
Collectively, these results demonstrate that T cells present in IPF lung have the potential to drive fibrotic mechanisms but CTLA-4 expression might impede this process.
Results:
Enrichment of T cell activation and proinflammatory pathways in IPF lung T cells.
Various investigators have reported that T cells from IPF patients are phenotypically and functionally distinct from T cells derived from normal donors 4, 8 .
Specifically, IPF T cells exhibit monoclonal and oligoclonal properties [10] [11] [12] , and react to autoantigens 13 . In the present study, RNAseq data analysis of lung-associated IPF T cells and normal peripheral T cells revealed that there were approximate 1850 transcripts significantly differentially expressed in IPF compared normal T cells ( Figure 1A ).
According to a KEGG pathway analysis, T cell activation pathways were enriched in IPF T cells (Table S1 ). The top most transcript group enriched in these cells was transcripts encoding for various lysosomal components (Figure 1B and Table S1 (Table S2) . Indeed, there was an enrichment of various transcripts previously shown to be abundantly expressed and/or to play a role in pulmonary remodeling ( Figure 1C ).
However, there was an overall reduction in transcripts encoding for the T cell costimulatory protein CD28 (Figure 1D ), which was consistent with previous reports 4, 8 .
Further, there was no evidence for Th2 or Th17 skewing in these cells based upon the lack of transcripts encoding for IL17, IL4, and IL13 (data not shown). T cells from one IPF patient (IPF2) showed abundant foxp3 expression but low TGF-b expression compared with the other IPF and normal cells analyzed ( Figure 1C-D) . Thus, these results demonstrate that IPF T cells exhibit an activated genotype.
Enrichment of immune checkpoint transcripts in IPF lung T cells.
As shown above, IPF T cells appeared to be more active than normal T cells but there was also a loss of co-stimulatory signaling proteins in these cells ( 4, 8, 9 , and see above), which is a feature commonly observed in aged and immune checkpoint-regulated T cells [15] [16] [17] [18] . Further, there was no conclusive evidence for T cell activation and/or T cell 
Discussion:
While the precise role of the immune system on the progression of IPF remains controversial, recent evidence suggest that immune pathways may be aberrantly activated in this disease [19] [20] [21] [22] [23] [24] and FOSB of the AP-1 transcription factor complex, which might be a consequence of T cell activation pathways including TCR signaling 26 . Paradoxically, our transcriptomic analysis of T cells revealed a universal down regulation of CD28 transcripts in IPF compared with normal T cells, which is consistent with various published reports documenting the loss of co-stimulatory proteins such as CD28 and ICOS on IPF T cells 4, 8, 9 . Loss of CD28 on T cells is a feature of antigen experienced, highly differentiated and aged T cells 15, 18, 27 , a finding that is consistent with the limited IPF T cell receptor repertoire we observed in our transcriptomic analysis (data not shown) and by others [10] [11] [12] [13] . Transcriptomic analysis of CD28-low IPF T cells revealed an abundance of T cell activation pathways and an enrichment of T cell mediated KEGG autoimmune pathways.
Indeed, several reports have observed an abundance of CD28(null) T cells in inflammatory disorders, including atherosclerosis, chronic viral infection and autoimmunity (reviewed in 27, 28 ). This is supported by a study showing the presence of 
Materials and Methods: Isolation of IPF explant cells and T cell sorting:
Normal and IPF lung explants were placed into sterile PBS, washed and transferred into fresh PBS. Tissue was minced and spun at 600 x g for 5 minutes.
Supernatants were collected with the PBS utilized to wash the explanted lungs (lung wash). The top layer of the pellet enriched in mechanically dissociated cells and red blood cells (RBCs) were strained through a 70-µm strainer, the strainer washed several times with DPBS to separate cells from the minced tissues. This procedure was repeated until the RBCs and dissociated cells were removed from the minced tissue pellet. The dissociated cells were mixed with the lung wash and spun down at 400 x g for 5 minutes.
RBCs were lysed using RBC lysis buffer (Biolegend) and cells were then counted and viably frozen down using CryoStor CS10 freezing medium (STEMCELL Technologies Inc.). For in vivo experiments, cells were rapidly thawed, washed in serum free medium and intravenously injected into NSG mice as described below. For in vivo experiments, cells were thawed out, T cells were magnetically sorted using anti-human CD3 microbeads (Miltenyi Biotech, 130-050-101), cultured on plastic dishes for 2 hours to deplete any contaminating antigen presenting cells, after which 100, 000 cells were intravenously injected into NOD/SCID mice.
Mice:
Six to eight-week old Pathogen free NOD Cg-Prkdc<SCID> IL2rg<Tm1wil>Szi 
Detection of IL12-p70, IFN-gamma and TNF-alpha in the BAL
Naïve and T cell challenged NOD/SCID mice were sacrificed and their lungs were lavaged using 1 ml of saline solution. BAL cells were spun down and the supernatants were frozen until analysis. IL12-p70, IFN-gamma and TNF-alpha levels in the BAL was measured using predesigned Bioplex assays (Bio-Rad) as recommended by the manufacturer.
Histological analysis:
Left 
Hydroxyproline assay:
Total lung hydroxyproline was analyzed as previously described 113 with a few modifications. Superior and middle lobes were surgically dissected, and placed into 5 ml sterile tubes and flash frozen until all the samples have been collected. On the day of the assay, tissues were thawed at room temperature and 500 µl of distilled water (dH 2 O) was added to the tissues. Tissues were homogenized using a micro-sample homogenizer (Pro 
RNAseq analysis:
CD3 + T cells were sorted from IPF explants and CD4+ cells were magnetically sorted from the peripheral blood of normal donors. RNA was extracted from the sorted cells and a minimum of 200 ng of total RNA was used, samples were sequenced using HiSeq 2000 SBS Sequencing v3. Raw reads in FASTQ format were aligned to the UCSC human reference genome (hg38) using CLC genomics workbench V8.5.1, RPKM values were generated and fold change and statistical significance were calculated using the Empirical analysis of DGE (EDGE; 41, 42 ). The resulting data were analyzed using QIAGEN's Ingenuity
Pathway Analysis (IPA, QIAGEN Redwood City, www.qiagen.com/ingenuity) and DAVID Bioinformatics Resources 6.7 43, 44 . Ingenuity IPA was set to only consider changes in gene expression of 1.5-fold or greater and a p value of 0.05 or less. Ingenuity upstream analysis was exported and is provided in Table S3 . For KEGG pathway analysis, average transcripts with an RPKM ≥ 100 in IPF T cells were uploaded into DAVID Bioinformatics Resources 6.7 (Huang da et al., 2009a) and KEGG pathway analysis were exported and is provided in Table S1 . For transcript expression for various profibrotic, T cell function and DNA repair transcripts, RPKM values from 3 normal and 3 IPF T cell datasets were imported into GENE-E (http://www.broadinstitute.org/cancer/software/GENE-E/), where heat maps depicting the normalized FPKM counts for each transcript were generated and depicted. Finally, T cell-associated markers and immune checkpoint receptors and ligands were compiled using the ingenuity pathway designer tool and transcript expression data from IPF bronchial brushings or T cells (relative to their normal, nonfibrotic, counterparts) were overlaid.
Analysis of gene expression arrays of IPF and normal bronchial brushings:
RNA was extracted from Normal and IPF bronchial brushing. RNA was then hybridized to probes and subject to microarray analysis. The resulting intensities from 6 IPF and 10 normal samples were averaged and the ratios of IPF-to-normal were calculated. The results were then uploaded onto ingenuity IPA for pathway analysis.
Ratios where then converted into fold change in Ingenuity IPA and analysis was set to consider transcripts showing a change of 1.5-fold or greater. The resulting analysis was then overlaid onto a custom generated T cell and immune checkpoint pathway interaction network using Ingenuity's pathway designer.
Flow cytometry:
Murine lungs and spleens:
Lungs were surgically dissected and placed into 1 ml of sterile complete medium on ice until all the lobes were collected. Murine lung cellular suspensions were generated using mouse lung dissociation kit, C-tubes and a GentleMacs dissociator (Miltenyi Biotech) as recommended by the manufacturer. Spleens were dissociated using a sterile rubber tip of 1 ml syringe plunger and 100 µm 50 ml tube filters (BD bioscience) as follows:
isolated spleens were placed in 1 ml of sterile complete medium until all the samples are collected. Sterile 50 ml conical tube filters were placed on top of sterile 50 ml conical tubes and were equilibrated by pipetting 1 ml of calcium and magnesium free DPBS (DBPS; Cellgro) through the filters. Using sterile forceps, spleens were transferred on top of a sterile 50 ml filter. Cellular suspensions were generated by mashing the spleens 
Gene expression array data mining and Ingenuity IPA analysis:
Publicly available gene expression datasets (GSE24206) were mined from NCBI's geo datasets database. Groups were defined as follows -IPF lung explants vs normal lung and IPF lung biopsies versus normal lungs. Gene expression values were extracted using NCBI's Geo2R gene expression analysis tool and the expression data were uploaded onto ingenuity IPA. Ingenuity IPA was set to only consider changes in gene expression of 1.5-fold or greater and p ≤ 0.05. The resulting data were then overlaid on a custom designed T cell marker and immune checkpoint receptor and ligand network.
Statistical analysis:
All statistical analyses were performed using GraphPad Prism software (GraphPad).
Study approval:
Institutional Review Board approval for the studies outlined herein was obtained at 
